Anti-tyrosinase antibodies in malignant melanoma

Cancer Immunology Immunotherapy

Volumn 42, Issue 5, 1996, Pages 297-302

  Merimsky, Ofer ^a,b,c,d   Baharav, Ehud ^c,d   Shoenfeld, Yehuda ^b,e   Chaitchik, Samario ^a,b   Tsigelman, Rosa ^c,d   Cohen Aloro, Dina ^c,d   Fishman, Pnina ^c,d  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d BAR ILAN UNIVERSITY   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

Anti tyrosinase antibodies; Malignant melanoma; Melanoma associated hypopigmentation; Vitilogi

Indexed keywords

AUTOANTIBODY; ENZYME ANTIBODY; MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOPIGMENTATION; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; VITILIGO;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; VITILIGO;

EID: 0029784664     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050286     Document Type: Article

References (26)

1. Agrup P, Carstam R, Wittbjer A, Rorsman H, Rosengren E (1989) Tyrosinase activity in serum from patients with malignant melanoma. Acta Derm Venereol (Stockh) 69: 120
2. Akutsu Y, Jimbow K (1986) Development and characterization of a mouse monoclonal antibody MoAb HMSA-1 against a melanosomal fraction of human malignant melanoma. Cancer Res 46: 2904
3. Baharav E, Merimsky O, Altomonte M, Shoenfeld Y, Pavlovic M, Maio M, Ferrone S, Fishman P (1995) Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigen. Melanoma Res 5: 337
4. Fitzpatrick TB, Eisen AZ, Waliff K, Freedberg I, Austen KF (1979) Dermatology in general medicine. McGraw Hill, New York
5. Glantz SA (1992) The t-test. In: Glants SA (ed) Primer of biostatistics. McGraw-Hill, New-York, p 67
6. Gupta RK, Morton DL (1984) Studies of a melanoma tumor associated antigen detected in the spent culture medium of a human melanoma cell line by an allogeneic antibody. III. Physicochemical properties. J Natl Cancer Inst 70: 83
7. Hearing VJ, Nicholson JM, Montague PM, Ekel TM, Tomecki KJ (1973) Mammalian tyrosinase structural and functional interrelashionship to isoenzymes. Biochim Biophys Acta 522: 327
8. Jimenez M, Lee Maloy W, Hearing VJ (1989) Specific identification of an authentic clone for mammalian tyrosinase. J Biol Chem 264: 3397
9. Kageshita T, Nakamura T, Yamada M, Kuriya N, Arao T, Ferrone S (1991) Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions. Cancer Res 51: 1726
10. Kameyama K, Takemura T, Hamada Y, Sakai C, Kondoh S, Nishiyama S, Urabe K, Hearing VJ (1993) Pigment production in murine melanoma cells is regulated by tyrosinase tyrosinase-related protein 1 (TRP1) DOPAchrome tautomerase (TRP2) and a melanogenic inhibitor. J Invest Dermatol 100: 126
11. Karg E, Hultberg B, Isaksson A, Rosengren E, Rorsman H (1990) Enzyme release from cultured human melanoma cells. Acta Derm Venereol (Stockh) 70: 286
12. Lynch SA, Bouchard BN, Vijayasaradhi S, Yuasa H, Houghton AN (1991) Antigens of melanocytes and melanoma. Cancer Metastasis Rev 10: 141
13. McEwan M, Parsons PG, Moss DJ (1988) Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells. J Invest Dermatol 90: 515
14. Merimsky O, Shoenfeld Y, Chaitchik S, Fishman P (1994) Antigens and antibodies in malignant melanoma. Tumor Biol 15: 188
15. Merimsky O, Shoenfeld Y, Yecheskel G, Chaitchik S, Azizi E, Fishman P (1994) Vitiligo and melanoma associated hypopigmentation: a similar appearance but a different mechanism. Cancer Immunol Immunother 38: 411
16. Naughton GK, Eisenger M, Bystryn JC (1983) Antibodies to normal human melanocytes in vitiligo. J Exp Med 158: 246
17. Nishioka K, Romsdahl MM, McMurtrey MJ (1979) Adaptation of triatiated tyrosinase assay to serum tyrosinase and its specific elevation in melanoma. In: SN Klaus (ed) Pigmented cell, vol 5. Karger, Basel, pp 300-304
18. Riley PA (1991) Melanogenesis: a realistic target for antimelanoma therapy? Eur J Cancer 27: 1172
19. Shibahara S, Tomita Y, Sakahura T, Nager C, Chaudhuri B, Muller R (1986) Cloning and expression of cDNA encoding mouse tyrosinase. Nucleic Acids Res 14: 2413
20. Sohn N, Gang H, Gumport SL, Goldstein M, Depisch LM (1969) Generalized melanosis secondary to malignant melanoma. Cancer 24: 897
21. Thomson TM, Jules Mattes M, Roux L, Old LJ, Lloyd KO (1985) Pigmentation associated glycoprotein of human melanomas and melanocytes: definition with a mouse monoclonal antibody. J Invest Dermatol 89: 169
22. Tomity Y, Montague PM, Hearing VJ (1985) Anti T4 tyrosinase monoclonal antibodies: specific markers for pigmented melanocytes. J Invest Dermatol 85: 426
23. Tsukamoto K, Jackson IJ, Urabe K, Montague PM, Hearing VJ (1992) A second tyrosinase-related protein TRP-2 is a melanogenic enzyme termed DOPAchrome tautomerase EMBO J 11: 519
24. Vennegoor C, Hageman PH, Van Nouhuijs H, Ruiter DJ, Calafat J, Ringens PJ, Rumke PH (1988) A monoclonal antibodyspecific for cells of the melanocyte lineage. Am J Pathol 130: 179
25. Wittbjer A, Odh G, Rosengren AM, Rosengren E, Rorsman H (1990) Isolation of soluble tyrosinase from human melanoma. Acta Derm Venereol (Stockholm) 70: 291
26. Yamamoto H, Takeuchi S, Kudo T, Sato C, Takeuchi T (1989) Melanin production in cultured albino melanocytes transfected with mouse tyrosinase cDNA. JpJ Genet 64: 121